{
  "schema_version": "2.0",
  "doc_id": "8f553fb846eaa975e1e09e0a83ac592c3a24f11e20ba44e4635f02e5ed3c9427",
  "extracted_at": "2026-02-01T08:37:30.779328+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "High-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "8fc496eafb26889796e8a92e9af68a26"
      ]
    },
    {
      "id": "ent_002",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "selective serotonin reuptake inhibitor"
      },
      "source_chunk_ids": [
        "8fc496eafb26889796e8a92e9af68a26"
      ]
    },
    {
      "id": "ent_003",
      "type": "Taxon",
      "name": "Sceletium spp.",
      "attributes": {
        "context": "Sceletium extract"
      },
      "source_chunk_ids": [
        "8fc496eafb26889796e8a92e9af68a26"
      ]
    },
    {
      "id": "ent_004",
      "type": "PharmEffect",
      "name": "monoamine releasing agent",
      "attributes": {
        "context": "is a monoamine releasing agent"
      },
      "source_chunk_ids": [
        "8fc496eafb26889796e8a92e9af68a26"
      ]
    },
    {
      "id": "ent_005",
      "type": "PharmEffect",
      "name": "selective serotonin reuptake inhibitor",
      "attributes": {
        "context": "a selective serotonin reuptake inhibitor"
      },
      "source_chunk_ids": [
        "8fc496eafb26889796e8a92e9af68a26"
      ]
    },
    {
      "id": "ent_006",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "alkaloids contained in plants"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_007",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "plants in the genus Sceletium"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "ligand",
      "attributes": {
        "context": "inhibit ligand binding"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_009",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "serotonin transporter"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_010",
      "type": "PharmEffect",
      "name": "inhibit ligand binding",
      "attributes": {
        "context": "reported to inhibit ligand binding"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_011",
      "type": "PharmEffect",
      "name": "selective serotonin-reuptake inhibitors",
      "attributes": {
        "context": "act as selective serotonin-reuptake inhibitors"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_012",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "anxiolytic or anti-depressant effect"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_013",
      "type": "PharmEffect",
      "name": "anti-depressant",
      "attributes": {
        "context": "anxiolytic or anti-depressant effect"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_014",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "such as monoamine release"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_015",
      "type": "PharmEffect",
      "name": "monoamine release",
      "attributes": {
        "context": "such as monoamine release"
      },
      "source_chunk_ids": [
        "2bec7cab4b9f089af0a036526bf28230"
      ]
    },
    {
      "id": "ent_016",
      "type": "PharmEffect",
      "name": "anxiolytic effects",
      "attributes": {
        "context": "evidence for anxiolytic effects of Sceletium products"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_017",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "anxiolytic effects of Sceletium products"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_018",
      "type": "Indication",
      "name": "restraint-induced stress",
      "attributes": {
        "context": "rat model of restraint-induced stress"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_019",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "inhibit serotonin binding"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_020",
      "type": "Compound",
      "name": "serotonin transporter",
      "attributes": {
        "context": "serotonin binding to the serotonin transporter"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_021",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "some of the alkaloids contained in Sceletium"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_022",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "alkaloids contained in Sceletium"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_023",
      "type": "Compound",
      "name": "phosphodiesterase 4A",
      "attributes": {
        "context": "inhibit phosphodiesterase 4A activity"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_024",
      "type": "Compound",
      "name": "mesembrenone",
      "attributes": {
        "context": "potency: mesembrenone"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_025",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "mesembrenone > mesembrine"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_026",
      "type": "Compound",
      "name": "mesembrenol",
      "attributes": {
        "context": "mesembrine > mesembrenol"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_027",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium acts as selective serotonin-reuptake inhibitor"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_028",
      "type": "PharmEffect",
      "name": "selective serotonin-reuptake inhibitor",
      "attributes": {
        "context": "Sceletium acts as selective serotonin-reuptake inhibitor"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_029",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "result in the anxiolytic"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_030",
      "type": "PharmEffect",
      "name": "anti-",
      "attributes": {
        "context": "or anti-"
      },
      "source_chunk_ids": [
        "8ff6dbea3e13cf813638f8475d442d67"
      ]
    },
    {
      "id": "ent_031",
      "type": "PharmEffect",
      "name": "depressant effect",
      "attributes": {
        "context": "depressant effect ascribed to Sceletium"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_032",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "depressant effect ascribed to Sceletium"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_033",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "such as monoamine release"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_034",
      "type": "PharmEffect",
      "name": "monoamine release",
      "attributes": {
        "context": "such as monoamine release"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_035",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "administration of SSRIs"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_036",
      "type": "PharmEffect",
      "name": "up-regulation of PDE4",
      "attributes": {
        "context": "linked to up-regulation of PDE4"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "up-regulation of PDE4"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_038",
      "type": "PharmEffect",
      "name": "hypersensitivity to SSRIs",
      "attributes": {
        "context": "subsequent hypersensitivity to SSRIs"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_039",
      "type": "PharmEffect",
      "name": "decreased PDE4 activity",
      "attributes": {
        "context": "report of decreased PDE4 activity"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_040",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "with Sceletium administration"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "SSRI",
      "attributes": {
        "context": "being a pure SSRI"
      },
      "source_chunk_ids": [
        "469c22959d9e2581b3e225a67aeb4fb6"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "Dulbecco's Modified Eagles medium (DMEM)",
      "attributes": {
        "context": "supplemented with Dulbecco's Modified Eagles medium (DMEM)"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_043",
      "type": "Compound",
      "name": "foetal bovine serum (FBS)",
      "attributes": {
        "context": "10% foetal bovine serum (FBS)"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_044",
      "type": "Compound",
      "name": "GA-1000",
      "attributes": {
        "context": "1% GA-1000"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_045",
      "type": "Compound",
      "name": "CO2",
      "attributes": {
        "context": "presence of 5% CO2"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {
        "context": "serotonin release and serotonin reuptake inhibition"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_047",
      "type": "PharmEffect",
      "name": "viability testing",
      "attributes": {
        "context": "for viability testing"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_048",
      "type": "PharmEffect",
      "name": "serotonin release",
      "attributes": {
        "context": "assessments related to serotonin release"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_049",
      "type": "PharmEffect",
      "name": "serotonin reuptake inhibition",
      "attributes": {
        "context": "serotonin reuptake inhibition"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_050",
      "type": "Concentration",
      "name": "10%",
      "attributes": {
        "context": "10% foetal bovine serum (FBS)"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_051",
      "type": "Concentration",
      "name": "1%",
      "attributes": {
        "context": "1% GA-1000"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_052",
      "type": "Concentration",
      "name": "5%",
      "attributes": {
        "context": "presence of 5% CO2"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_053",
      "type": "Concentration",
      "name": "37 \u00b0C",
      "attributes": {
        "context": "at 37 \u00b0C"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_054",
      "type": "Concentration",
      "name": "80%",
      "attributes": {
        "context": "At 80% confluence"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_055",
      "type": "Concentration",
      "name": "7.5 \u00d7 10^4",
      "attributes": {
        "context": "7.5 \u00d7 104 astrocytes"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_056",
      "type": "Concentration",
      "name": "1 \u00d7 10^6",
      "attributes": {
        "context": "1 \u00d7 106 GT1-7 cells per well"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_057",
      "type": "Concentration",
      "name": "8 \u00d7 10^4",
      "attributes": {
        "context": "8 \u00d7 104 astrocytes"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_058",
      "type": "Concentration",
      "name": "1 \u00d7 10^5",
      "attributes": {
        "context": "1 \u00d7 105 GT1-7 cells"
      },
      "source_chunk_ids": [
        "1e8b2fb77485c748b20c4586f8a185f7"
      ]
    },
    {
      "id": "ent_059",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "percentage of various alkaloids"
      },
      "source_chunk_ids": [
        "74396405fe328148db132ca64801f5a7"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "\u03947-mesembranone",
      "attributes": {
        "context": "\u03947-mesembranone at approximately 2.1 minutes"
      },
      "source_chunk_ids": [
        "74396405fe328148db132ca64801f5a7"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "mesembranone",
      "attributes": {
        "context": "mesembranone at approximately 3.1 minutes"
      },
      "source_chunk_ids": [
        "74396405fe328148db132ca64801f5a7"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "mesembrine at approximately 4.1 minutes"
      },
      "source_chunk_ids": [
        "74396405fe328148db132ca64801f5a7"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_064",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_065",
      "type": "Concentration",
      "name": "1 mg/ml",
      "attributes": {
        "context": "extract (TRI, 1 mg/ml"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_066",
      "type": "Concentration",
      "name": "0.1 mg/ml",
      "attributes": {
        "context": "1 mg/ml, 0.1 mg/ml"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_067",
      "type": "Concentration",
      "name": "0.01 mg/ml",
      "attributes": {
        "context": "0.1 mg/ml, 0.01 mg/ml"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_068",
      "type": "Concentration",
      "name": "0.001 mg/ml",
      "attributes": {
        "context": "0.01 mg/ml, 0.001 mg/ml"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_069",
      "type": "Concentration",
      "name": "0.0001 mg/ml",
      "attributes": {
        "context": "0.001 mg/ml and 0.0001 mg/ml"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "DMEM",
      "attributes": {
        "context": "dissolving it in DMEM"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_071",
      "type": "Concentration",
      "name": "24 h",
      "attributes": {
        "context": "for a period of 24 h"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_072",
      "type": "PharmEffect",
      "name": "mitochondrial viability",
      "attributes": {
        "context": "mitochondrial viability was assessed"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "MTT",
      "attributes": {
        "context": "using the MTT assay"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_074",
      "type": "PharmEffect",
      "name": "neurophysiological effects",
      "attributes": {
        "context": "assessment of neurophysiological effects"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_075",
      "type": "Concentration",
      "name": "15 min",
      "attributes": {
        "context": "treatment for 15 as well as 30-min"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_076",
      "type": "Concentration",
      "name": "30-min",
      "attributes": {
        "context": "15 as well as 30-min"
      },
      "source_chunk_ids": [
        "340c7c12c3ee26c806be72103ce925cd"
      ]
    },
    {
      "id": "ent_077",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium extract"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_078",
      "type": "Compound",
      "name": "Sceletium extract",
      "attributes": {
        "context": "exposure to Sceletium extract"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_079",
      "type": "Compound",
      "name": "Citalopram",
      "attributes": {
        "context": "10 \u00b5M Citalopram"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_080",
      "type": "Concentration",
      "name": "10 \u00b5M",
      "attributes": {
        "context": "10 \u00b5M Citalopram"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_081",
      "type": "Compound",
      "name": "paraformaldehyde",
      "attributes": {
        "context": "using 4% paraformaldehyde"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_082",
      "type": "Concentration",
      "name": "4%",
      "attributes": {
        "context": "4% paraformaldehyde"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_083",
      "type": "Compound",
      "name": "phosphate buffer solution",
      "attributes": {
        "context": "phosphate buffer solution (PBS)"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_084",
      "type": "Compound",
      "name": "Triton X-100",
      "attributes": {
        "context": "0.05% Triton X-100"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_085",
      "type": "Concentration",
      "name": "0.05%",
      "attributes": {
        "context": "0.05% Triton X-100"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_086",
      "type": "Compound",
      "name": "bovine serum albumin",
      "attributes": {
        "context": "1% bovine serum albumin (BSA)"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_087",
      "type": "Concentration",
      "name": "1%",
      "attributes": {
        "context": "1% bovine serum albumin"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_088",
      "type": "Compound",
      "name": "vesicular monoamine transporter 2 primary antibody",
      "attributes": {
        "context": "binding of the vesicular monoamine transporter 2 (VMAT-2) primary antibody"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_089",
      "type": "Compound",
      "name": "serotonin reuptake transporter primary antibody",
      "attributes": {
        "context": "the serotonin reuptake transporter (SERT) primary antibody"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "Secondary antibodies",
      "attributes": {
        "context": "Secondary antibodies used"
      },
      "source_chunk_ids": [
        "bbe6b936d4e97f3489235066c0117442"
      ]
    },
    {
      "id": "ent_091",
      "type": "Compound",
      "name": "Sceletium extract",
      "attributes": {
        "context": "by the Sceletium extract"
      },
      "source_chunk_ids": [
        "a1c5f9c1e8e47521b919b01709653d0e"
      ]
    },
    {
      "id": "ent_092",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "reports on Sceletium"
      },
      "source_chunk_ids": [
        "a1c5f9c1e8e47521b919b01709653d0e"
      ]
    },
    {
      "id": "ent_093",
      "type": "PharmEffect",
      "name": "cell viability",
      "attributes": {
        "context": "cell viability was not influenced"
      },
      "source_chunk_ids": [
        "a1c5f9c1e8e47521b919b01709653d0e"
      ]
    },
    {
      "id": "ent_094",
      "type": "Concentration",
      "name": "any dose",
      "attributes": {
        "context": "at any dose"
      },
      "source_chunk_ids": [
        "a1c5f9c1e8e47521b919b01709653d0e"
      ]
    },
    {
      "id": "ent_095",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "TRI 0.001"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_096",
      "type": "PharmEffect",
      "name": "cell viability",
      "attributes": {
        "context": "24hr cell viability (%control)"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_097",
      "type": "PharmEffect",
      "name": "viability",
      "attributes": {
        "context": "show viability around 100%"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_098",
      "type": "Concentration",
      "name": "0.001",
      "attributes": {
        "context": "TRI 0.001"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_099",
      "type": "Concentration",
      "name": "0.01",
      "attributes": {
        "context": "TRI 0.01"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_100",
      "type": "Concentration",
      "name": "0.1",
      "attributes": {
        "context": "TRI 0.1"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_101",
      "type": "Concentration",
      "name": "1",
      "attributes": {
        "context": "TRI 1"
      },
      "source_chunk_ids": [
        "492835162c23792366537ee057b5ee0d"
      ]
    },
    {
      "id": "ent_102",
      "type": "Compound",
      "name": "citalopram",
      "attributes": {
        "context": "citalopram significantly down-regulated SERT expression"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_103",
      "type": "PharmEffect",
      "name": "down-regulated SERT expression",
      "attributes": {
        "context": "citalopram significantly down-regulated SERT expression"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_104",
      "type": "PharmEffect",
      "name": "down-regulation of SERT",
      "attributes": {
        "context": "clear down-regulation of SERT"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_105",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "higher dose TRI treatment"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_106",
      "type": "Concentration",
      "name": "1 mg/ml",
      "attributes": {
        "context": "1 mg/ml TRI showed results"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_107",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "1 mg/ml TRI showed results"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_108",
      "type": "Compound",
      "name": "citalopram",
      "attributes": {
        "context": "comparable to those of the citalopram standard"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_109",
      "type": "Concentration",
      "name": "0.1 mg/ml",
      "attributes": {
        "context": "0.1 mg/ml TRI had effects"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_110",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "0.1 mg/ml TRI had effects"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_111",
      "type": "Compound",
      "name": "citalopram",
      "attributes": {
        "context": "similar to that of citalopram"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_112",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "effect of TRI on SERT down-regulation"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_113",
      "type": "PharmEffect",
      "name": "SERT down-regulation",
      "attributes": {
        "context": "effect of TRI on SERT down-regulation"
      },
      "source_chunk_ids": [
        "db0eb7272230ad64c601ac5fb48e983c"
      ]
    },
    {
      "id": "ent_114",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine extract"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_115",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "TRI acted as modulator"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_116",
      "type": "PharmEffect",
      "name": "enzyme inhibition potential",
      "attributes": {
        "context": "enzyme inhibition potential"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_117",
      "type": "PharmEffect",
      "name": "modulator of enzyme function",
      "attributes": {
        "context": "modulator of enzyme function"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_118",
      "type": "PharmEffect",
      "name": "total inhibitor",
      "attributes": {
        "context": "total inhibitor"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_119",
      "type": "Compound",
      "name": "acetylcholine esterase",
      "attributes": {
        "context": "For acetylcholine esterase (AChE)"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_120",
      "type": "Compound",
      "name": "AChE",
      "attributes": {
        "context": "For acetylcholine esterase (AChE)"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_121",
      "type": "PharmEffect",
      "name": "low to moderate inhibition",
      "attributes": {
        "context": "low to moderate inhibition was evident"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_122",
      "type": "PharmEffect",
      "name": "~30% inhibition",
      "attributes": {
        "context": "only ~30% inhibition was seen"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_123",
      "type": "Concentration",
      "name": "2 mg/ml TRI",
      "attributes": {
        "context": "at a dose of 2 mg/ml TRI"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_124",
      "type": "Compound",
      "name": "galanthamine",
      "attributes": {
        "context": "galanthamine achieved a 30% inhibition"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_125",
      "type": "PharmEffect",
      "name": "30% inhibition",
      "attributes": {
        "context": "galanthamine achieved a 30% inhibition"
      },
      "source_chunk_ids": [
        "b17350f636fa6551e4fb688c3a03fd5a"
      ]
    },
    {
      "id": "ent_126",
      "type": "Compound",
      "name": "galantamine",
      "attributes": {
        "context": "galantamine (solid squares)"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_127",
      "type": "Compound",
      "name": "Acetylcholinesterase",
      "attributes": {
        "context": "Acetylcholinesterase (AChE) inhibition"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_128",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_129",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_130",
      "type": "PharmEffect",
      "name": "AChE inhibition",
      "attributes": {
        "context": "showing AChE inhibition"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_131",
      "type": "PharmEffect",
      "name": "% AChE inhibition",
      "attributes": {
        "context": "% AChE inhibition at extract concentrations"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_132",
      "type": "PharmEffect",
      "name": "inhibition",
      "attributes": {
        "context": "increase in inhibition"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_133",
      "type": "PharmEffect",
      "name": "Acetylcholinesterase (AChE) inhibition",
      "attributes": {
        "context": "Acetylcholinesterase (AChE) inhibition by high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_134",
      "type": "Concentration",
      "name": "2 mg/ml",
      "attributes": {
        "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_135",
      "type": "Concentration",
      "name": "0.2 mg/ml",
      "attributes": {
        "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_136",
      "type": "Concentration",
      "name": "0.02 mg/ml",
      "attributes": {
        "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_137",
      "type": "Concentration",
      "name": "0.002 mg/ml",
      "attributes": {
        "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
      },
      "source_chunk_ids": [
        "70c89f0f90f569ebfe9c0f3e7431e8ae"
      ]
    },
    {
      "id": "ent_138",
      "type": "PharmEffect",
      "name": "Acetylcholinesterase inhibition",
      "attributes": {
        "context": "Acetylcholinesterase inhibition induced by high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_139",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_140",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_141",
      "type": "Compound",
      "name": "galantamine",
      "attributes": {
        "context": "in comparison to galantamine"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_142",
      "type": "PharmEffect",
      "name": "acetylcholinesterase inhibitor",
      "attributes": {
        "context": "galantamine (acetylcholinesterase inhibitor drug for Alzheimer's disease)"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_143",
      "type": "Indication",
      "name": "Alzheimer's disease",
      "attributes": {
        "context": "drug for Alzheimer's disease"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_144",
      "type": "Concentration",
      "name": "12.4 \u00b5g/ml",
      "attributes": {
        "context": "IC_{50} value for galantamine was 12.4 \\mug/ml"
      },
      "source_chunk_ids": [
        "6ebf5d76301b6ce3c08039a718cd38dc"
      ]
    },
    {
      "id": "ent_145",
      "type": "PharmEffect",
      "name": "MAO-A inhibition",
      "attributes": {
        "context": "MAO-A inhibition induced by the extract"
      },
      "source_chunk_ids": [
        "d2b389343991690617fbf0ddc5795b61"
      ]
    },
    {
      "id": "ent_146",
      "type": "Compound",
      "name": "clorgyline",
      "attributes": {
        "context": "comparison to clorgyline"
      },
      "source_chunk_ids": [
        "d2b389343991690617fbf0ddc5795b61"
      ]
    },
    {
      "id": "ent_147",
      "type": "PharmEffect",
      "name": "irreversible and selective inhibitor of MAO-A",
      "attributes": {
        "context": "clorgyline (irreversible and selective inhibitor of MAO-A)"
      },
      "source_chunk_ids": [
        "d2b389343991690617fbf0ddc5795b61"
      ]
    },
    {
      "id": "ent_148",
      "type": "Concentration",
      "name": "407.9 \\mug/ml",
      "attributes": {
        "context": "407.9 \\mug/ml for the extract"
      },
      "source_chunk_ids": [
        "d2b389343991690617fbf0ddc5795b61"
      ]
    },
    {
      "id": "ent_149",
      "type": "Concentration",
      "name": "0.015 \\mug/ml",
      "attributes": {
        "context": "0.015 \\mug/ml for clorgyline"
      },
      "source_chunk_ids": [
        "d2b389343991690617fbf0ddc5795b61"
      ]
    },
    {
      "id": "ent_150",
      "type": "Concentration",
      "name": "0.0025 mg/ml",
      "attributes": {
        "context": "0.0025 mg/ml"
      },
      "source_chunk_ids": [
        "ca0c2dc76876d019bdcb924ba6ef3ff6"
      ]
    },
    {
      "id": "ent_151",
      "type": "Compound",
      "name": "galanthamine",
      "attributes": {
        "context": "galanthamine"
      },
      "source_chunk_ids": [
        "ca0c2dc76876d019bdcb924ba6ef3ff6"
      ]
    },
    {
      "id": "ent_152",
      "type": "Concentration",
      "name": "12.4 \u00b5g/ml",
      "attributes": {
        "context": "12.4 \u00b5g/ml"
      },
      "source_chunk_ids": [
        "ca0c2dc76876d019bdcb924ba6ef3ff6"
      ]
    },
    {
      "id": "ent_153",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "TRI"
      },
      "source_chunk_ids": [
        "ca0c2dc76876d019bdcb924ba6ef3ff6"
      ]
    },
    {
      "id": "ent_154",
      "type": "PharmEffect",
      "name": "mild SSRI activity",
      "attributes": {
        "context": "despite its mild SSRI activity"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_155",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "such as cocaine"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_156",
      "type": "Compound",
      "name": "sertraline",
      "attributes": {
        "context": "and sertraline"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_157",
      "type": "PharmEffect",
      "name": "SSRI",
      "attributes": {
        "context": "function as SSRI"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_158",
      "type": "Compound",
      "name": "SERT",
      "attributes": {
        "context": "blocking of SERT"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_159",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {
        "context": "such as amphetamine"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_160",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {
        "context": "and methamphetamine"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_161",
      "type": "PharmEffect",
      "name": "addictive effect",
      "attributes": {
        "context": "the addictive (award) effect"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_162",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "effect of cocaine"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_163",
      "type": "Compound",
      "name": "SERT",
      "attributes": {
        "context": "inhibition of both SERT"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_164",
      "type": "Compound",
      "name": "dopamine transporter",
      "attributes": {
        "context": "and dopamine transporter (DAT)"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_165",
      "type": "Compound",
      "name": "DAT",
      "attributes": {
        "context": "dopamine transporter (DAT)"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_166",
      "type": "PharmEffect",
      "name": "withdrawal symptoms",
      "attributes": {
        "context": "the withdrawal symptoms"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_167",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "after cocaine or alcohol abuse"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_168",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {
        "context": "or alcohol abuse"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_169",
      "type": "Taxon",
      "name": "Sceletium sp.",
      "attributes": {
        "context": "another Sceletium extract"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_170",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "alkaloids mesembrine"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_171",
      "type": "Compound",
      "name": "mesembrenone",
      "attributes": {
        "context": "mesembrenone"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_172",
      "type": "Compound",
      "name": "mesembrenol",
      "attributes": {
        "context": "and mesembrenol"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_173",
      "type": "PharmEffect",
      "name": "inhibition of dopamine transporters",
      "attributes": {
        "context": "no significant inhibition of dopamine transporters"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_174",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium products"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_175",
      "type": "Taxon",
      "name": "Sceletium sp.",
      "attributes": {
        "context": "high-mesembrine Sceletium products"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_176",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "treatment of cocaine addiction"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_177",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "ability of TRI"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_178",
      "type": "Compound",
      "name": "VMAT-2",
      "attributes": {
        "context": "up-regulate VMAT-2"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_179",
      "type": "Indication",
      "name": "neuronal dopamine abnormalities",
      "attributes": {
        "context": "involve neuronal dopamine abnormalities"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_180",
      "type": "Indication",
      "name": "Parkinson's disease",
      "attributes": {
        "context": "such as Parkinson's disease"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_181",
      "type": "Compound",
      "name": "VMAT-2",
      "attributes": {
        "context": "modulation of VMAT-2"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_182",
      "type": "Indication",
      "name": "cocaine addiction",
      "attributes": {
        "context": "cocaine and alcohol addiction"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_183",
      "type": "Indication",
      "name": "alcohol addiction",
      "attributes": {
        "context": "and alcohol addiction"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_184",
      "type": "Indication",
      "name": "Parkinson's disease",
      "attributes": {
        "context": "also Parkinson's disease"
      },
      "source_chunk_ids": [
        "3ed20463c6f9b261ea91e84d887e4633"
      ]
    },
    {
      "id": "ent_185",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_186",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "high-mesembrine Sceletium"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_187",
      "type": "PharmEffect",
      "name": "monoamine releasing agent",
      "attributes": {
        "context": "potential as monoamine releasing agent"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_188",
      "type": "Compound",
      "name": "monoamine oxidase type A (MAO-A)",
      "attributes": {
        "context": "inhibition of monoamine oxidase type A (MAO-A) activity"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_189",
      "type": "PharmEffect",
      "name": "mild inhibition",
      "attributes": {
        "context": "showed only a mild inhibition of monoamine oxidase type A (MAO-A) activity"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_190",
      "type": "Compound",
      "name": "MAO-A",
      "attributes": {
        "context": "MAO-A plays an important role"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_191",
      "type": "PharmEffect",
      "name": "metabolism",
      "attributes": {
        "context": "metabolism of intracellular neurotransmitters"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_192",
      "type": "Compound",
      "name": "neurotransmitters",
      "attributes": {
        "context": "metabolism of intracellular neurotransmitters"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_193",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "context of especially depression"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_194",
      "type": "PharmEffect",
      "name": "MAO-A inhibition",
      "attributes": {
        "context": "MAO-A inhibition \u2013 which results in less intracellular monoamine breakdown"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_195",
      "type": "PharmEffect",
      "name": "less intracellular monoamine breakdown",
      "attributes": {
        "context": "results in less intracellular monoamine breakdown"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_196",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "less intracellular monoamine breakdown"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_197",
      "type": "Indication",
      "name": "neurodegenerative disorders",
      "attributes": {
        "context": "treatment of neurodegenerative disorders"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_198",
      "type": "Indication",
      "name": "Alzheimer's",
      "attributes": {
        "context": "Alzheimer's and Parkinson's disease"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_199",
      "type": "Indication",
      "name": "Parkinson's disease",
      "attributes": {
        "context": "Alzheimer's and Parkinson's disease"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_200",
      "type": "Compound",
      "name": "MAO-A",
      "attributes": {
        "context": "downregulation of MAO-A by methamphetamine"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_201",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {
        "context": "downregulation of MAO-A by methamphetamine"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_202",
      "type": "PharmEffect",
      "name": "downregulation",
      "attributes": {
        "context": "excessive downregulation of MAO-A"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_203",
      "type": "PharmEffect",
      "name": "chronic pulmonary toxicity",
      "attributes": {
        "context": "linked to chronic pulmonary toxicity"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_204",
      "type": "Compound",
      "name": "MAO inhibitors",
      "attributes": {
        "context": "use of MAO inhibitors"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_205",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "monoamine releasing agents such as MDMA"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_206",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {
        "context": "monoamine releasing agents such as MDMA"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_207",
      "type": "PharmEffect",
      "name": "low level inhibition",
      "attributes": {
        "context": "low level inhibition reported here"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_208",
      "type": "Compound",
      "name": "MAO inhibitors",
      "attributes": {
        "context": "MAO inhibitors are known to inhibit the P450 enzymes"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_209",
      "type": "PharmEffect",
      "name": "inhibit",
      "attributes": {
        "context": "known to inhibit the P450 enzymes"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_210",
      "type": "Compound",
      "name": "P450 enzymes",
      "attributes": {
        "context": "inhibit the P450 enzymes"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_211",
      "type": "PharmEffect",
      "name": "targeted inhibition",
      "attributes": {
        "context": "targeted inhibition of specific P450 enzymes"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_212",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "specific P450 enzymes by high-dose TRI"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_213",
      "type": "Concentration",
      "name": "high-dose",
      "attributes": {
        "context": "by high-dose TRI"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_214",
      "type": "Compound",
      "name": "steroid",
      "attributes": {
        "context": "context of steroid synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_215",
      "type": "PharmEffect",
      "name": "steroid synthesis",
      "attributes": {
        "context": "context of steroid synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_216",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "TRI also alleviated"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_217",
      "type": "PharmEffect",
      "name": "alleviated",
      "attributes": {
        "context": "TRI also alleviated forskolin- and angiotensin II-induced aldosterone synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_218",
      "type": "Compound",
      "name": "forskolin",
      "attributes": {
        "context": "alleviated forskolin- and angiotensin II-induced aldosterone synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_219",
      "type": "Compound",
      "name": "angiotensin II",
      "attributes": {
        "context": "forskolin- and angiotensin II-induced aldosterone synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_220",
      "type": "Compound",
      "name": "aldosterone",
      "attributes": {
        "context": "aldosterone synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_221",
      "type": "PharmEffect",
      "name": "aldosterone synthesis",
      "attributes": {
        "context": "aldosterone synthesis"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_222",
      "type": "PharmEffect",
      "name": "anti-hypertension effect",
      "attributes": {
        "context": "suggesting an anti-hypertension effect"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_223",
      "type": "Concentration",
      "name": "high dose",
      "attributes": {
        "context": "at high dose only"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_224",
      "type": "PharmEffect",
      "name": "mild MAO-A inhibition",
      "attributes": {
        "context": "only mild MAO-A inhibition"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_225",
      "type": "Compound",
      "name": "MAO-A",
      "attributes": {
        "context": "only mild MAO-A inhibition"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_226",
      "type": "PharmEffect",
      "name": "mild inhibition",
      "attributes": {
        "context": "relatively mild inhibition of MAO-A"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_227",
      "type": "Compound",
      "name": "MAO-A",
      "attributes": {
        "context": "mild inhibition of MAO-A"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_228",
      "type": "PharmEffect",
      "name": "cytotoxicity",
      "attributes": {
        "context": "not cause cytotoxicity"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_229",
      "type": "Concentration",
      "name": "large doses",
      "attributes": {
        "context": "even at large doses"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_230",
      "type": "PharmEffect",
      "name": "counter-medication",
      "attributes": {
        "context": "employed as counter-medication"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_231",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "counter-medication in addiction"
      },
      "source_chunk_ids": [
        "bdfc4cc5ef861c54e1286e37c0dbb93d"
      ]
    },
    {
      "id": "ent_232",
      "type": "Compound",
      "name": "MAO-A",
      "attributes": {
        "context": "As for MAO-A, our data indicates"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_233",
      "type": "Compound",
      "name": "acetylcholinesterase (AChE)",
      "attributes": {
        "context": "inhibition of acetylcholinesterase (AChE) activity"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_234",
      "type": "Compound",
      "name": "TRI",
      "attributes": {
        "context": "activity by TRI."
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_235",
      "type": "PharmEffect",
      "name": "mild inhibition of acetylcholinesterase (AChE) activity",
      "attributes": {
        "context": "a rather mild inhibition of acetylcholinesterase (AChE) activity"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_236",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "report on Sceletium extract"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_237",
      "type": "Concentration",
      "name": "1 mg/ml",
      "attributes": {
        "context": "in which 1 mg/ml of pure mesembrine"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_238",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "pure mesembrine achieved only a \u2248 30% AChE inhibition"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_239",
      "type": "PharmEffect",
      "name": "\u2248 30% AChE inhibition",
      "attributes": {
        "context": "achieved only a \u2248 30% AChE inhibition"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_240",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "alkaloid extract from Sceletium tortuosum"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_241",
      "type": "PharmEffect",
      "name": "inhibited AChE in a dose-dependent manner",
      "attributes": {
        "context": "inhibited AChE in a dose-dependent manner"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_242",
      "type": "Concentration",
      "name": "1 mg/ml",
      "attributes": {
        "context": "assessed (1 mg/ml) resulting in 87% inhibition"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_243",
      "type": "PharmEffect",
      "name": "87% inhibition",
      "attributes": {
        "context": "resulting in 87% inhibition"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_244",
      "type": "PharmEffect",
      "name": "inhibitory effects on AChE activity",
      "attributes": {
        "context": "plant's inhibitory effects on AChE activity"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_245",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "low mesembrine content was reported"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_246",
      "type": "PharmEffect",
      "name": "inhibit acetylcholinesterase activity by 7%",
      "attributes": {
        "context": "only inhibit acetylcholinesterase activity by 7%"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_247",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "extract and alkaloids, which may have been too low"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_248",
      "type": "PharmEffect",
      "name": "therapeutic effect",
      "attributes": {
        "context": "achieve therapeutic effect in this context"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_249",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "indigenous use of Sceletium"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_250",
      "type": "PharmEffect",
      "name": "inhibitory effect",
      "attributes": {
        "context": "may well have an inhibitory effect"
      },
      "source_chunk_ids": [
        "45e503f85c29a70aa488abc1aa0041e2"
      ]
    },
    {
      "id": "ent_251",
      "type": "Compound",
      "name": "acetylcholinesterase",
      "attributes": {
        "context": "on acetylcholinesterase activity"
      },
      "source_chunk_ids": [
        "036089bf1e209f301d5c2a14cf49f2a8"
      ]
    },
    {
      "id": "ent_252",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high mesembrine content"
      },
      "source_chunk_ids": [
        "036089bf1e209f301d5c2a14cf49f2a8"
      ]
    },
    {
      "id": "ent_253",
      "type": "PharmEffect",
      "name": "inhibitory capacity",
      "attributes": {
        "context": "lost this inhibitory capacity"
      },
      "source_chunk_ids": [
        "036089bf1e209f301d5c2a14cf49f2a8"
      ]
    },
    {
      "id": "ent_254",
      "type": "PharmEffect",
      "name": "potentiation",
      "attributes": {
        "context": "loss of potentiation"
      },
      "source_chunk_ids": [
        "036089bf1e209f301d5c2a14cf49f2a8"
      ]
    },
    {
      "id": "ent_255",
      "type": "Compound",
      "name": "alkaloids",
      "attributes": {
        "context": "other minor alkaloids"
      },
      "source_chunk_ids": [
        "036089bf1e209f301d5c2a14cf49f2a8"
      ]
    },
    {
      "id": "ent_256",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_257",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_258",
      "type": "PharmEffect",
      "name": "anti-depressant effect",
      "attributes": {
        "context": "exerts its anti-depressant effect"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_259",
      "type": "PharmEffect",
      "name": "monoamine releasing agent",
      "attributes": {
        "context": "acting primarily as monoamine releasing agent"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_260",
      "type": "PharmEffect",
      "name": "selective serotonin-reuptake inhibitor",
      "attributes": {
        "context": "rather than as selective serotonin-reuptake inhibitor"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_261",
      "type": "PharmEffect",
      "name": "Enzyme inhibition",
      "attributes": {
        "context": "Enzyme inhibition data suggests"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_262",
      "type": "PharmEffect",
      "name": "low risk for toxicity",
      "attributes": {
        "context": "may have low risk for toxicity"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_263",
      "type": "PharmEffect",
      "name": "mild modulator",
      "attributes": {
        "context": "potential as mild modulator"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_264",
      "type": "Indication",
      "name": "attention deficit disorders",
      "attributes": {
        "context": "conditions such as attention deficit disorders"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    },
    {
      "id": "ent_265",
      "type": "Indication",
      "name": "Alzheimer's disease",
      "attributes": {
        "context": "and Alzheimer's disease"
      },
      "source_chunk_ids": [
        "85b1a63524666ad7497b457088f194fe"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:03.961807+00:00",
    "original_file": "entities.json"
  }
}